During the past decade, Iidabashi Skin Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Iidabashi Skin Clinic" are "Dermatitis, Atopic" (2 trials), "Dermatitis" (1 trials), "Eczema" (1 trials), "Genetic Diseases, Inborn" (1 trials) and "Hypersensitivity" (1 trials). Many other conditions were trialed in "Iidabashi Skin Clinic" in a lesser frequency.

Most popular intervention types in "Iidabashi Skin Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "Dupilumab" (1 trials), "Injectable Placebo" (1 trials) and "Oral Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Iidabashi Skin Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Iidabashi Skin Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Iidabashi Skin Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Iidabashi Skin Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".